Investigators concluded, “No adverse drug effects emerged during treatment.”
Year: 2023
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
The legislation will make it easier for qualified patients to register for the state’s medical cannabis access program and for physicians to participate in it.
Participants reported statistically significant improvements in their quality of life and employment status following cannabis treatment.
“[T]he ability of whole-plant cannabis extracts to reduce opioid reward and drug seeking behavior appears quite robust and of great clinical utility,” authors concluded.
Investigators concluded, “Medicinal cannabis, in a balanced formulation, may address a variety of conditions and can be safely prescribed by a medical doctor.”
“Overall, there is no clear evidence that [legalization] had any effect on rates of ED visits and hospitalizations for either motor vehicle or pedestrian/cyclist injury,” authors determined.
The pending legislation raises the amount of THC-infused products patients can legally possess.
NORML opposes HB 1053 because it unduly interferes with doctor/patient relations.